Vaccinia
Findings from San Raffaele Scientific Institute broaden understanding of vaccinia
Published in Gene Therapy Weekly, February 25th, 2010
Data detailed in 'The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use' have been presented. "Modified vaccinia virus Ankara (MVA) is employed as a human vaccine vector for the high expression of heterologous genes and the lack of replication in mammalian cells. This study demonstrates that cells infected by recombinant viruses can be obtained by fluorescence-activated cell sorting," scientists writing in the Journal of Virological Methods report.
"Recombinant viruses are generated by a swapping event between a red fluorescent protein...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2010-02-25)
More Articles from Gene Therapy Weekly
- Tufts University, Health Sciences
Researchers develop new tool for gene delivery - Blindness
Studies by D.C. Chung and co-authors describe new findings in blindness - Colon Cancer
Research from University of Kentucky reveals new findings on colon cancer - Diabetes
New diabetes research from University of Miami described - Diabetes
New findings in diabetes described from National Institute of Diabetes and Digestive and Kidney Disease - Escherichia coli
New Escherichia coli study findings reported from R.Z. Zhang and co-authors - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
